IMARC Group, a leading market research company, has recently releases report titled “Structural Heart Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global structural heart imaging market share, size, growth, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Structural Heart Imaging

Structural heart imaging is the process of using advanced medical imaging methods to capture real-time or static images of the anatomical structures of the heart and its functionality. It offers high-resolution images, allowing healthcare professionals to examine intricate heart structures with precision. It encompasses various modalities, such as echocardiography, cardiac magnetic resonance imaging (MRI), and computed tomography (CT) scans, providing versatility in diagnostics. It aids in the accurate diagnosis of heart conditions, including congenital defects, valve disorders, and cardiomyopathies. It assists in treatment planning by helping physicians understand the exact location and severity of heart abnormalities. It allows for ongoing monitoring of heart conditions, helping in disease management. It supports medical research by providing valuable data for developing new treatment modalities and improving existing ones. It helps identify and track cardiomyopathies, such as hypertrophic or dilated cardiomyopathy. It is widely used to evaluate and monitor conditions like aortic stenosis, mitral regurgitation, and other valvular diseases.

How Big Is the Structural Heart Imaging Market?

The global structural heart imaging market size reached US$ 19.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 44.2 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032.

Request Sample Copy of This Report: https://www.imarcgroup.com/structural-heart-imaging-market/requestsample

What are the growth prospects and trends in the structural heart imaging industry?

The increasing prevalence of cardiovascular diseases, including congenital heart defects and valvular disorders, represents one of the primary factors propelling the market growth. Additionally, the expanding and changing lifestyles are resulting in higher instances of heart-related issues, which, in turn, is driving the demand for advanced diagnostic tools like structural heart imaging to diagnose and treat these conditions accurately.

Furthermore, technological advancements in imaging modalities are enhancing the capabilities of structural heart imaging. Innovations in cardiac magnetic resonance imaging (MRI) and computed tomography (CT) scans are enabling higher-resolution imaging, providing healthcare professionals with more detailed and precise insights into the anatomical structures of the heart. Additionally, rising healthcare expenditure is supporting the adoption of advanced medical imaging technologies.

Besides this, various public and private healthcare providers are investing in upgrading their healthcare infrastructure, including the installation of state-of-the-art imaging equipment, which is offering a favorable market outlook. Furthermore, the rising collaborations between medical device companies and academic institutions are facilitating research and development (R&D) activities.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Imaging Modality:

  • Echocardiogram
  • Angiogram
    • CT
    • MRI

Breakup by Procedure Type:

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Surgical Aortic Valve Replacement (SAVR)
  • Transcatheter Mitral Valve Repair (TMVR)
  • Left Atrial Appendage Closure (LAAC)
  • Annuloplasty
  • Valvuloplasty
  • Others

Breakup by Application:

  • Diagnosis
  • Surgery

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Cardiac Centers
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Catheterization Laboratories
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V. and Siemens Healthcare GmbH.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163